» Articles » PMID: 16650970

Characterisation of the Onset and Presenting Clinical Features of Adult Bronchiectasis

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2006 May 3
PMID 16650970
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is little information available on the features of initial presentation of bronchiectasis and documentation of the onset and progress of symptoms leading up to this. Therefore a study was performed on a large cohort of adult patients presenting to Monash Medical Centre (MMC) to survey the course of their disease up to the time of diagnosis.

Objectives: To characterise the onset and presenting clinical features of bronchiectasis in adults.

Methods: A cross-sectional study of 103 adults presenting to a tertiary referral hospital with newly diagnosed bronchiectasis. Clinical features of bronchiectasis and results of spirometry, sputum microbiology and radiology were assessed and correlated.

Results: Most patients had idiopathic bronchiectasis (74%) and did not have other significant disease. The dominant symptom was chronic productive cough present in 98% of patients with other important symptoms being chronic rhinosinusitis (70%), dyspnoea (62%), and fatigue (74%). Most patients had had a chronic productive cough for over 30 years prior to diagnosis and over 80% of patients had chronic respiratory symptoms from childhood. The dominant finding on physical examination was the presence of crackles which were generally bi-basal. Spirometry showed mild airway obstruction with an average forced expiratory volume in 1s of the cohort of 76% predicted. Radiologic imaging generally showed multilobar disease (80%).

Conclusions: The typical profile of bronchiectasis in this group of patients was of longstanding productive cough, rhinosinusitis and fatigue in non-smokers with crackles on chest auscultation.

Citing Articles

Heart rate recovery after the 6-min walk test in people with bronchiectasis.

Saez-Perez J, Arbillaga-Etxarri A, Alcaraz-Serrano V, Gimeno-Santos E, Torres A, Herrero-Cortina B ERJ Open Res. 2025; 11(2).

PMID: 40040890 PMC: 11873979. DOI: 10.1183/23120541.00694-2024.


Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.

Tsouprou M, Koumpagioti D, Botsa E, Douros K, Moriki D Antibiotics (Basel). 2025; 14(2).

PMID: 40001409 PMC: 11851904. DOI: 10.3390/antibiotics14020165.


Characteristics of different pathogenic bacterial infections and their effects on prognosis in adult patients with bronchiectasis.

Niu Y, Lian X, Li X, Ge X, Wang H Exp Ther Med. 2024; 28(6):455.

PMID: 39478731 PMC: 11523220. DOI: 10.3892/etm.2024.12745.


A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.

Guo Z, Gu S, Tian Z, Du B Front Med (Lausanne). 2024; 11:1437731.

PMID: 39386750 PMC: 11461384. DOI: 10.3389/fmed.2024.1437731.


Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis.

Wang P, Shu C, Sheu C, Chang C, Hsieh M, Hsu W Open Forum Infect Dis. 2024; 11(8):ofae427.

PMID: 39145140 PMC: 11322833. DOI: 10.1093/ofid/ofae427.